Articles From: Baxter Declares Quarterly Dividend to Baytex Confirms Monthly Dividend for February at $0.22 Per Share


2013/2/19
The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.45 per Baxter common share.
Sign-up for Baxter Declares Quarterly Dividend investment picks
2013/3/27
Baxter International (NYSE:BAX) , will host a quarterly conference call to discuss its first quarter 2013 financial results on Thursday, April 18, 2013, at 7:30 a.m. Central Time.
Sign-up for Baxter International First Quarter 2013 Financial Results Conference Call investment picks
2013/4/16
Baxter International Inc. (NYSE:BAX) today announced its continued commitment to the hemophilia community to close the gap in hemophilia care and the company’s vision to pursue a bleed-free world for people living with this debilitating disorder on World Hemophilia Day.
Sign-up for Baxter Marks World Hemophilia Day by Reinforcing Commitment to Addressing Disparities in Care and Sharing New Vision for the Future investment picks
2013/4/24
Baxter International Inc. (NYSE:BAX) today announced Phase I/II data evaluating the safety and immunogenicity of its investigational Lyme disease candidate vaccine during the National Foundation for Infectious Diseases 16 th Annual Conference on Vaccine Research in Baltimore, Md.
Sign-up for Baxter Presents Phase I/II Data Evaluating Lyme Disease Vaccine at NFID Annual Conference on Vaccine Research investment picks
2013/5/6
Baxter International Inc. (NYSE:BAX) today announced it is increasing its dividend for shareholders by nine percent.
Sign-up for Baxter Raises Dividend Nine Percent investment picks
2013/2/26
Baxter International Inc. (NYSE:BAX) today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.
Sign-up for Baxter Submits Application for FDA Approval of FEIBA NF for Prophylactic Use in Hemophilia A and B Patients with Inhibitors investment picks
2013/4/2
Baxter International Inc. (NYSE: BAX) is incorporating innovative technologies and has recently established new partnerships in its commitment to environmental sustainability and increasing access to healthcare.
Sign-up for Baxter Taps New Technologies, Forms Collaborations to Improve Environmental Sustainability and Access to Healthcare investment picks
2013/2/27
Baxter International Inc. (NYSE: BAX) announced today that it will present at the Raymond James 34 th Annual Institutional Investors Conference on Tuesday, March 5, 2013 at 7:05 a.m. (CT). The live webcast of Baxter’s presentation along with the slides can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through April 4, 2013.
Sign-up for Baxter to Present at Raymond James 34th Annual Institutional Investors Conference investment picks
2013/4/25
Baxter International Inc. (NYSE: BAX) announced today that it will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Tuesday, May 14, 2013 at 5:40 p.m. (CT). The live webcast of Baxter’s presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through June 13, 2013.
Sign-up for Baxter to Present at the Bank of America Merrill Lynch 2013 Health Care Conference investment picks
2013/2/7
Baxter International Inc. (NYSE: BAX) announced today that it will present at the Citi 2013 Global Healthcare Conference on Monday, February 25, 2013 at 2:00 p.m. (CT) and the 2013 RBC Capital Markets Healthcare Conference on Tuesday, February 26, 2013 at 8:00 a.m. (CT) The live webcast of Baxter’s presentation along with the slides can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through March 25, 2013.
Sign-up for Baxter to Present at Upcoming Global Healthcare Conferences investment picks
2013/4/24
Baxter International Inc. (NYSE: BAX) will webcast its annual meeting of shareholders on Tuesday, May 7, 2013, at 9:00 a.m. Central Time.
Sign-up for Baxter to Webcast Annual Meeting of Shareholders investment picks
2013/5/7
Baxter International Inc. (BAX) said results from a late-stage study of its potential treatment for Alzheimer's, immunoglobulin, were negative.
Sign-up for Baxter's Potential Alzheimer's Treatment Immunoglobulin Misses Primary Endpoints investment picks
2013/4/29
Bayer AG (BAYRY, BAYN.XE) has agreed to buy Conceptus Inc. (CPTS) for about $1.1 billion ( 852 million euros ) as the health-care firm aims to broaden its women's contraceptive offerings.
Sign-up for Bayer Agrees to Buy Conceptus for $1.1 Billion in Cash investment picks
2013/4/16
Germany's Bayer AG (BAYN.XE) said Tuesday its CropScience unit and Monsanto Co.
Sign-up for Bayer and Monsanto Enter Into Licensing Agreements investment picks
2013/5/7
LEVERKUSEN, Germany and WAYNE, N.J. , May 7, 2013 /PRNewswire/ -- Bayer's planned acquisition of Conceptus, Inc., based in Mountain View, California (NASDAQ: CPTS) is entering its next phase: Evelyn Acquisition Company, a subsidiary established by Bayer HealthCare LLC, Tarrytown, N.Y. , for the purpose of the acquisition, is commencing today a cash tender offer for all the shares of Conceptus, Inc. at a price of US$31.00 per share.
Sign-up for Bayer commences cash tender offer for all outstanding shares of Conceptus, Inc. investment picks
2013/4/16
Agreements Create More Options for Farmers and Expanded Market Opportunities for Next-Generation Technologies MONHEIM, Germany and ST.
Sign-up for Bayer CropScience And Monsanto Enter Into Cross-Licensing Agreements For Next-Generation And Enabling Technologies investment picks
2013/4/29
MOUNTAIN VIEW, Calif.
Sign-up for Bayer HealthCare to Acquire Conceptus(R) investment picks
2013/4/16
WAYNE, N.J. , April 16, 2013 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.
Sign-up for Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia investment picks
2013/4/29
German chemicals and pharmaceuticals group Bayer AG (BAYN.SE) said Monday it will acquire California -based Conceptus Inc. (CPTS) in a deal that values the company at $1.1 billion , to bolster its flagging contraceptives business.
Sign-up for Bayer to Acquire Conceptus to Bolster Contraceptive Business investment picks
2013/4/29
Adds Essure®, the only non-surgical permanent birth control method, to Bayer's contraception portfolio WAYNE, N.J. and MOUNTAIN VIEW, Calif.
Sign-up for Bayer to acquire Conceptus, Inc. investment picks
2013/2/25
WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif.
Sign-up for Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable or Metastatic GIST investment picks
2013/3/25
WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif.
Sign-up for Bayer's Stivarga® (regorafenib) Tablets Approved in Japan investment picks
2013/4/24
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0868820001&sourceType=1 http://www.ccnmatthews.com/logos/20110215-bayfield.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Bayfield Adopts An Advance Notice Policy for Election of Directors investment picks
2013/4/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0868393001&sourceType=1 http://www.ccnmatthews.com/logos/20110215-bayfield.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Bayfield Drills 11.0m of 12.19 g/t Gold and 30.05 g/t Silver in Rainy River, NW Ontario investment picks
2013/4/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0864443001&sourceType=1 http://www.ccnmatthews.com/logos/20110215-bayfield.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Bayfield Ventures AGM Held- Directors Re-elected investment picks
2013/4/18
STURGEON BAY, Wis.
Sign-up for Baylake Corp. Reports Net Income Growth, Significant Continued Asset Quality Improvements in First Quarter 2013 investment picks
2013/4/4
Greenway Medical Technologies, Inc. announced today that Baylor Quality Alliance (BQA), which has a mission to improve quality and reduce the overall cost of care for patients and communities it serves, has selected Greenway to participate in BQA’s electronic health record (EHR) program.
Sign-up for Baylor Quality Alliance Selects Greenway for Participation in EHR Program investment picks
2013/2/13
Baylor Dallas to deliver high quality, coordinated patient care with Sunrise Clinical Manager CHICAGO , Feb.
Sign-up for Baylor University Medical Center activates Allscripts electronic health record system investment picks
2013/3/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0857734001&sourceType=1 http://www.ccnmatthews.com/logos/20110114-baytex_200.jpg CALGARY, ALBERTA --
Sign-up for Baytex Conference Call On Fourth Quarter and Year-End 2012 Results To Be Held March 7, 2013 investment picks
2013/2/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0853316001&sourceType=1 http://www.ccnmatthews.com/logos/20110114-baytex_200.jpg CALGARY, ALBERTA --
Sign-up for Baytex Confirms Monthly Dividend for February at $0.22 Per Share investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Baxter Declares Quarterly Dividend to Baytex Confirms Monthly Dividend for February at $0.22 Per Share
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity